Position in JNJ
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$169,940,215
-$406,109 QoQ
Shares Held
669,135
-4.0% QoQ
Ownership
0.028%
of shares outstanding
% of Portfolio
0.82%
of 13F equity value
Holder Rank
#224
of 4,664 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Bridgewater Associates, LP holds $365,428,487 across 9 Drug Manufacturers - General names. JNJ ranks #1 (46.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
669,135 | $169,940,215 | |
| 2 | LLY |
ELI LILLY & Co
|
87,023 | $104,378,005 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
290,881 | $36,749,905 | |
| 4 | GSK |
GSK plc
|
504,171 | $26,428,643 | |
| 5 | SNY |
Sanofi
|
206,873 | $8,825,202 | |
| 6 | AMGN |
Amgen Inc
|
21,869 | $7,919,202 | |
| 7 | PFE |
Pfizer Inc
|
180,092 | $4,336,615 | |
| 8 | MRK |
Merck & Co., Inc.
|
30,254 | $3,887,639 |
All Filings in JNJ
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $169,940,215 | 669,135 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $170,346,324 | 696,884 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $271,923,608 | 1,313,958 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $318,139,371 | 1,715,777 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $348,657,832 | 2,282,539 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $49,302,241 | 297,288 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $77,796,448 | 537,937 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $238,247,809 | 1,470,121 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $468,341,218 | 3,204,305 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $449,771,028 | 2,843,233 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $434,904,440 | 2,774,687 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $424,318,291 | 2,724,355 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $526,589,962 | 3,181,428 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $556,054,905 | 3,587,451 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $630,267,415 | 3,567,888 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $769,836,123 | 4,712,513 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $769,085,683 | 4,332,633 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $770,064,704 | 4,345,002 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $529,930,723 | 3,097,742 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $444,776,814 | 2,754,036 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $465,078,482 | 2,823,106 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $281,021,243 | 1,709,895 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $231,312,245 | 1,469,769 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $99,065,049 | 665,402 | Shares | Sole | 2020-11-13 | |
| 2020-03-31 | $1,077,232 | 8,215 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||